Avantor (AVTR) announced that Ludovic Brellier will join the company as executive VP, Bioscience & Medtech Products & Chief Transformation Officer on May 1. Brellier will be responsible for growing the BMP business and improving operational performance. He joins Avantor from Danaher, where he was most recently President of Cytiva’s Hardware Solutions business, leading five business units responsible for early innovation through manufacturing and commercialization of services for the biopharma industry.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR:
- Avantor unifies Masterflex portfolio to include fluid handling
- Avantor price target lowered to $7 from $8.50 at Barclays
- Avantor adds advanced microbial, stability testing at St. Louis site
- Avantor price target lowered to $8.50 from $10 at Evercore ISI
- ESAB says R. Brent Jones to succeed Kevin Johnson as CFO